Literature DB >> 15166387

Association between cerebral ischemia and cytotoxin-associated gene-A-bearing strains of Helicobacter pylori.

Michael R Preusch1, Armin J Grau, Florian Buggle, Christoph Lichy, Jan Bartel, Carmen Black, Jochen Rudi.   

Abstract

BACKGROUND AND
PURPOSE: Studies on Helicobacter pylori infection and risk of ischemic stroke yielded variable results. Infection with more virulent H. pylori strains, such as cytotoxin-associated gene-A (CagA)-bearing strains, may be of particular relevance for ischemic diseases. We investigated whether H. pylori and CagA seropositivity are independent risk factors for cerebral ischemia or its etiologic subtypes.
METHODS: We determined IgG antibodies against H. pylori and CagA protein (enzyme immunoassays) in 190 patients with acute cerebral ischemia and in 229 age- and sex-matched control subjects selected randomly from the general population.
RESULTS: CagA seropositivity was more common in patients (114/190; 60.0%) than in control subjects (99/229; 43.2%; odds ratio, 1.97; 95% CI, 1.33 to 2.91; P<0.001). This result remained significant after adjustment for age, sex, vascular risk factors and diseases, and childhood and adult social status (odds ratio, 1.84; 95% CI, 1.13 to 3.00; P=0.015). Subgroup analyses yielded similar results in all etiologic stroke subtypes. In contrast, H. pylori seropositivity in general was not associated with increased risk of stroke or its etiologic subtypes.
CONCLUSIONS: Our results support the hypothesis of an association between infection with CagA-positive H. pylori strains and acute cerebral ischemia.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15166387     DOI: 10.1161/01.STR.0000131751.35926.48

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  CagA-positive Helicobacter pylori strains enhanced coronary atherosclerosis by increasing serum OxLDL and HsCRP in patients with coronary heart disease.

Authors:  Bingsheng Huang; Ying Chen; Qiang Xie; Guixiong Lin; Yuyan Wu; Yanlin Feng; Jingcao Li; Yufeng Zhuo; Peng Zhang
Journal:  Dig Dis Sci       Date:  2010-05-26       Impact factor: 3.199

2.  Role of anti-infective strategies in the prevention of stroke.

Authors:  Armin J Grau
Journal:  Curr Treat Options Cardiovasc Med       Date:  2005-07

3.  Helicobacter pylori infection contributes to high risk of ischemic stroke: evidence from a meta-analysis.

Authors:  Zhong Wei Wang; Yan Li; Li Yong Huang; Qing Kai Guan; Da Wei Xu; Wen Ke Zhou; Xin Zhong Zhang
Journal:  J Neurol       Date:  2012-06-12       Impact factor: 4.849

4.  Influence of CagA-positive Helicobacter pylori strains on atherosclerotic carotid disease.

Authors:  Petra Bago Rožanković; Arijana Lovrenčić Huzjan; Hrvoje Cupić; Ines Jajić Benčić; Silvio Bašić; Vida Demarin
Journal:  J Neurol       Date:  2010-11-18       Impact factor: 4.849

Review 5.  Common infections and the risk of stroke.

Authors:  Armin J Grau; Christian Urbanek; Frederick Palm
Journal:  Nat Rev Neurol       Date:  2010-11-09       Impact factor: 42.937

6.  Infectious burden and risk of stroke: the northern Manhattan study.

Authors:  Mitchell S V Elkind; Pankajavalli Ramakrishnan; Yeseon P Moon; Bernadette Boden-Albala; Khin M Liu; Steve L Spitalnik; Tanja Rundek; Ralph L Sacco; Myunghee C Paik
Journal:  Arch Neurol       Date:  2009-11-09

7.  Relationship between the cytotoxin-associated gene-A status of H pylori strains and cerebral infarction in European Caucasians and Chinese Han: a meta-analysis.

Authors:  Shuo Zhang; Yang Guo; Yan Ma; Yue Teng
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

8.  Helicobacter pylori serum antibody titers in patients with cerebral non-cardioembolic ischemic stroke.

Authors:  Seyed Ali Mousavi; Behrooz Ataei; Iraj Karimi; Kamyar Ashrafi
Journal:  J Res Med Sci       Date:  2011-03       Impact factor: 1.852

9.  No associations of Helicobacter pylori infection and gastric atrophy with plasma total homocysteine in Japanese.

Authors:  Simon Itou; Yasuyuki Goto; Takaaki Kondo; Kazuko Nishio; Sayo Kawai; Yoshiko Ishida; Mariko Naito; Nobuyuki Hamajima
Journal:  Int J Med Sci       Date:  2007-03-14       Impact factor: 3.738

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.